Last 7 days
-17%
Last 30 days
-7.0%
Last 90 days
-11.8%
Trailing 12 Months
-17.2%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-08-07 | Garg Pushkal | sold | -766,083 | 183 | -4,166 | cmo & evp dev & med affairs |
2023-08-04 | Vaishnaw Akshay | sold | -753,986 | 185 | -4,057 | president |
2023-08-04 | Greenstreet Yvonne | sold | -753,986 | 185 | -4,057 | chief executive officer |
2023-08-04 | Poulton Jeffrey V. | sold | -643,037 | 185 | -3,460 | evp, chief financial officer |
2023-08-04 | Garg Pushkal | sold | -643,223 | 185 | -3,461 | cmo & evp dev & med affairs |
2023-08-03 | Poulton Jeffrey V. | acquired | - | - | 7,627 | evp, chief financial officer |
2023-08-03 | Vaishnaw Akshay | acquired | - | - | 8,941 | president |
2023-08-03 | BONNEY MICHAEL W | sold | -1,195,310 | 185 | -6,448 | - |
2023-08-03 | Greenstreet Yvonne | acquired | - | - | 8,941 | chief executive officer |
2023-08-03 | Garg Pushkal | acquired | - | - | 7,627 | cmo & evp dev & med affairs |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-12 | Farther Finance Advisors, LLC | added | 31.25 | 784 | 3,989 | -% |
2023-08-29 | EFG Asset Management (Americas) Corp. | added | 3.66 | -51,951 | 2,988,710 | 0.69% |
2023-08-28 | DT Investment Partners, LLC | unchanged | - | -64.00 | 946 | -% |
2023-08-24 | Alberta Investment Management Corp | unchanged | - | -30,102 | 550,826 | -% |
2023-08-21 | BOKF, NA | reduced | -2.88 | -81,914 | 952,739 | 0.02% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -2.29 | -2,995,740 | 37,721,700 | 0.05% |
2023-08-21 | OSAIC HOLDINGS, INC. | added | 7.57 | 17,343 | 771,759 | -% |
2023-08-21 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | reduced | -16.59 | -2,617,000 | 9,894,000 | 0.10% |
2023-08-18 | Humankind Investments LLC | new | - | 211,403 | 211,403 | 0.08% |
2023-08-17 | Orion Portfolio Solutions, LLC | reduced | -5.15 | -50,096 | 447,499 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | price t rowe associates inc /md/ | 3.3% | 4,074,144 | SC 13G/A | |
Feb 13, 2023 | capital world investors | 13.5% | 16,593,958 | SC 13G/A | |
Feb 09, 2023 | fmr llc | - | 0 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 9.35% | 11,507,116 | SC 13G/A | |
Feb 06, 2023 | wellington management group llp | 5.09% | 6,261,642 | SC 13G/A | |
Jan 31, 2023 | blackrock inc. | 7.0% | 8,665,702 | SC 13G/A | |
Jan 19, 2023 | baillie gifford & co | 7.65% | 9,407,871 | SC 13G/A | |
Sep 09, 2022 | capital world investors | 10.7% | 12,816,777 | SC 13G | |
Feb 14, 2022 | price t rowe associates inc /md/ | 5.4% | 6,535,368 | SC 13G | |
Feb 09, 2022 | vanguard group inc | 8.95% | 10,702,771 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Aug 07, 2023 | 4 | Insider Trading | |
Aug 07, 2023 | 4 | Insider Trading | |
Aug 07, 2023 | 4 | Insider Trading | |
Aug 07, 2023 | 4 | Insider Trading | |
Aug 07, 2023 | 144 | Notice of Insider Sale Intent | |
Aug 04, 2023 | 4 | Insider Trading | |
Aug 03, 2023 | 8-K | Current Report | |
Aug 03, 2023 | 10-Q | Quarterly Report | |
Jul 26, 2023 | 8-K | Current Report | |
Jun 30, 2023 | 8-K | Current Report |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABBV | 271.4B | 56.0B | 2.30% | 9.45% | 31.25 | 4.84 | -2.31% | -31.27% |
BGNE | 265.4B | 1.8B | -1.67% | 25.43% | -153.19 | 146.56 | 69.45% | 14.65% |
VRTX | 90.8B | 9.5B | 0.45% | 22.78% | 26.99 | 9.56 | 13.83% | 5.33% |
REGN | 89.0B | 12.7B | -1.51% | 18.09% | 20.7 | 7.02 | -10.94% | -24.40% |
ALNY | 21.9B | 1.2B | -7.00% | -17.21% | -20.61 | 17.72 | 39.94% | -8.44% |
SRPT | 11.0B | 1.0B | 3.70% | 3.57% | -12.12 | 10.97 | 20.15% | -79.16% |
UTHR | 10.5B | 2.1B | -3.12% | 8.08% | 12.05 | 4.98 | 18.01% | 38.16% |
MID-CAP | ||||||||
BPMC | 3.1B | 225.6M | 0.04% | -28.00% | -5.53 | 13.59 | -2.11% | 21.02% |
MDGL | 3.0B | - | -10.01% | 147.80% | -9.03 | - | - | -28.88% |
RARE | 2.6B | 402.9M | -2.14% | -20.15% | -3.59 | 6.42 | 20.50% | -42.46% |
MRTX | 1.9B | 27.2M | -14.18% | -57.07% | -2.57 | 69.63 | - | -14.43% |
SMALL-CAP | ||||||||
CYTK | 3.1B | - | -2.94% | -39.70% | -7.31 | 33.28 | 34.30% | -149.91% |
CPRX | 1.3B | 302.9M | -16.58% | -4.84% | 11.18 | 4.26 | 77.72% | 112.02% |
MGNX | 281.2M | 152.5M | -11.67% | 38.41% | 37.75 | 1.84 | 127.84% | 103.41% |
CRBP | 28.7M | - | 1.35% | 3552.08% | -0.62 | - | - | -31.51% |
11.9%
12.3%
13.2%
9.9%
100%
36.9%
17.7%
Y-axis is the maximum loss one would have experienced if Alnylam Pharmaceuticals was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | 8.2% | 1,237,385,000 | 1,143,449,000 | 1,037,418,000 | 960,918,000 | 884,245,000 | 879,980,000 | 844,287,000 | 749,314,000 | 687,534,000 | 570,943,000 | 492,853,000 | 400,972,000 | 345,180,000 | 285,932,000 | 219,750,000 | 169,102,000 | 153,655,467 | 138,208,933 | 122,762,400 | 107,315,867 | 91,869,333 |
Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 719,688,000 |
S&GA Expenses | 5.6% | 844,551,000 | 799,846,000 | 770,658,000 | 746,696,000 | 652,912,000 | 628,251,000 | 620,639,000 | 600,548,000 | 625,945,000 | 608,518,000 | 588,420,000 | 578,406,000 | 531,285,000 | 516,158,000 | 479,005,000 | 431,416,000 | 427,610,000 | 399,520,000 | 382,359,000 | 341,126,000 | 272,225,000 |
R&D Expenses | 4.5% | 986,505,000 | 943,691,000 | 883,015,000 | 850,026,000 | 799,227,000 | 776,150,000 | 792,156,000 | 731,575,000 | 698,786,000 | 671,147,000 | 654,819,000 | 687,651,000 | 686,664,000 | 695,558,000 | 655,114,000 | 584,849,000 | 563,998,000 | 537,690,000 | 505,420,000 | 492,156,000 | 447,463,000 |
EBITDA | 100.0% | - | -868,365,000 | -926,557,000 | -975,871,000 | -773,788,000 | -694,931,000 | -661,556,000 | -654,141,000 | -717,113,000 | -716,458,000 | -736,332,000 | -802,777,000 | -792,519,000 | -873,101,000 | -868,078,000 | - | - | - | - | - | - |
EBITDA Margin | 100.0% | - | -0.76 | -0.89 | -1.02 | -0.88 | -0.79 | -0.78 | -0.87 | -1.04 | -1.25 | -1.49 | -2.00 | -2.30 | -3.05 | -3.95 | - | - | - | - | - | - |
Interest Expenses | -8.8% | 129,987,000 | 142,561,000 | 155,968,000 | 162,871,000 | 162,061,000 | 152,868,000 | 143,021,000 | 134,722,000 | 123,179,000 | 117,011,000 | 84,496,000 | 55,979,000 | 27,248,000 | - | - | - | - | - | - | - | - |
Earnings Before Taxes | 0.0% | -1,059,535,000 | -1,059,999,000 | -1,126,993,000 | -1,180,274,000 | -978,567,000 | -892,225,000 | -852,144,000 | -835,441,000 | -883,657,000 | -873,229,000 | -855,600,000 | -888,584,000 | -845,061,000 | -885,679,000 | -885,253,000 | -819,750,000 | -855,658,000 | -800,618,000 | -760,674,000 | -691,821,000 | -569,921,000 |
EBT Margin | 100.0% | - | -0.93 | -1.09 | -1.23 | -1.11 | -1.01 | -1.01 | -1.11 | -1.29 | -1.53 | -1.74 | -2.22 | -2.45 | -3.10 | -4.03 | - | - | - | - | - | - |
Net Income | 0.1% | -1,063,538,000 | -1,064,916,000 | -1,131,156,000 | -1,182,123,000 | -980,717,000 | -892,874,000 | -852,824,000 | -837,904,000 | -886,681,000 | -876,351,000 | -858,281,000 | -890,926,000 | -846,170,000 | -886,422,000 | -886,116,000 | -821,372,000 | -858,119,000 | -802,198,000 | -761,497,000 | -692,283,000 | -569,938,000 |
Net Income Margin | 100.0% | - | -0.93 | -1.09 | -1.23 | -1.11 | -1.01 | -1.01 | -1.12 | -1.29 | -1.53 | -1.74 | -2.22 | -2.45 | -3.10 | -4.03 | - | - | - | - | - | - |
Free Cashflow | 100.0% | - | -604,647,000 | -613,333,000 | -631,747,000 | -660,051,000 | -654,279,000 | -718,065,000 | -690,850,000 | -653,496,000 | -672,382,000 | -685,322,000 | -775,295,000 | -871,241,000 | -451,802,000 | -418,583,000 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | 0.3% | 3,402 | 3,392 | 3,546 | 3,535 | 3,330 | 3,434 | 3,643 | 3,472 | 3,509 | 3,255 | 3,407 | 3,307 | 3,374 | 2,280 | 2,395 | 2,542 | 2,716 | 2,014 | 1,575 | 1,676 | 1,789 |
Current Assets | -0.7% | 2,524 | 2,541 | 2,692 | 2,691 | 2,472 | 2,590 | 2,809 | 2,675 | 2,725 | 2,470 | 2,615 | 2,555 | 2,160 | 1,585 | 1,716 | 1,897 | 2,064 | 1,392 | 1,201 | 1,342 | 1,503 |
Cash Equivalents | -2.1% | 658 | 672 | 866 | 1,073 | 576 | 534 | 822 | 1,094 | 746 | 380 | 497 | 497 | 581 | 468 | 547 | 923 | 1,136 | 725 | 420 | 317 | 361 |
Inventory | -23.8% | 100 | 132 | 129 | 115 | 89.00 | 79.00 | 86.00 | 98.00 | 84.00 | 74.00 | 75.00 | 67.00 | 77.00 | 68.00 | 56.00 | 55.00 | 41.00 | 32.00 | 24.00 | 11.00 | - |
Net PPE | 0.8% | 527 | 523 | 523 | 515 | 508 | 504 | 502 | 485 | 471 | 465 | 465 | 445 | 439 | 430 | 425 | 396 | 372 | 342 | 321 | 273 | 228 |
Liabilities | 4.4% | 3,811 | 3,651 | 3,705 | 3,603 | 3,154 | 3,032 | 3,055 | 2,716 | 2,656 | 2,329 | 2,391 | 2,092 | 1,975 | 930 | 956 | 935 | 959 | 467 | 273 | 198 | 169 |
Current Liabilities | 17.1% | 789 | 673 | 768 | 773 | 658 | 606 | 696 | 611 | 555 | 495 | 585 | 480 | 384 | 339 | 353 | 353 | 329 | 149 | 179 | 122 | 114 |
Long Term Debt | - | - | - | - | - | 678 | 677 | 676 | 434 | 433 | 192 | 191 | - | - | - | - | - | - | - | - | - | - |
Shareholder's Equity | -57.4% | -408 | -259 | -158 | - | 176 | 401 | 588 | 756 | 853 | 926 | 1,016 | 1,215 | 1,400 | 1,350 | 1,439 | 1,607 | 1,757 | 1,547 | 1,302 | 1,478 | 1,621 |
Retained Earnings | -4.1% | -7,019 | -6,743 | -6,569 | -6,361 | -5,955 | -5,678 | -5,438 | -5,179 | -4,975 | -4,785 | -4,585 | -4,341 | -4,088 | -3,909 | -3,727 | -3,450 | -3,242 | -3,022 | -2,840 | -2,629 | -2,384 |
Additional Paid-In Capital | 1.9% | 6,647 | 6,522 | 6,455 | 6,337 | 6,173 | 6,117 | 6,058 | 5,969 | 5,863 | 5,747 | 5,644 | 5,593 | 5,520 | 5,290 | 5,201 | 5,091 | 5,034 | 4,602 | 4,175 | 4,140 | 4,038 |
Shares Outstanding | 0.5% | 125 | 124 | 124 | 123 | 121 | 120 | 120 | 119 | 118 | 117 | 116 | 116 | 115 | 113 | 112 | 109 | 109 | 105 | 101 | 101 | 101 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | 11.9% | -472 | -536 | -541 | -559 | -578 | -577 | -641 | -614 | -590 | -604 | -614 | -687 | -760 | -336 | -278 | -232 | -204 | -595 | -562 | -515 | -459 |
Share Based Compensation | 18.8% | 287 | 241 | 231 | 232 | 138 | 139 | 166 | 155 | 159 | 161 | 140 | 172 | 181 | 177 | 175 | 137 | 179 | 170 | 158 | 157 | 95.00 |
Cashflow From Investing | -63.0% | 89.00 | 241 | 169 | -104 | -506 | -492 | -273 | 42.00 | 120 | -477 | -435 | -558 | -558 | -406 | -417 | 52.00 | 158 | 510 | 273 | -136 | -369 |
Cashflow From Financing | 5.3% | 460 | 437 | 426 | 655 | 931 | 1,231 | 1,247 | 1,173 | 633 | 992 | 995 | 817 | 763 | 486 | 823 | 788 | 822 | 415 | 65.00 | 767 | 783 |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Revenues: | ||||
Total revenues | $ 318,754 | $ 224,818 | $ 638,044 | $ 438,077 |
Operating costs and expenses: | ||||
Cost of goods sold | 75,336 | 34,038 | 116,768 | 57,495 |
Cost of collaborations and royalties | 10,034 | 6,770 | 23,471 | 18,940 |
Research and development | 248,526 | 205,712 | 479,095 | 375,605 |
Selling, general and administrative | 214,689 | 169,984 | 398,348 | 324,455 |
Total operating costs and expenses | 548,585 | 416,504 | 1,017,682 | 776,495 |
Loss from operations | (229,831) | (191,686) | (379,638) | (338,418) |
Other (expense) income: | ||||
Interest expense | (30,035) | (42,609) | (58,990) | (84,971) |
Interest income | 21,075 | 1,899 | 39,730 | 2,911 |
Other expense, net | (35,418) | (42,277) | (47,673) | (93,551) |
Total other expense, net | (44,378) | (82,987) | (66,933) | (175,611) |
Loss before income taxes | (274,209) | (274,673) | (446,571) | (514,029) |
Provision for income taxes | (1,815) | (2,729) | (3,554) | (3,714) |
Net loss | $ (276,024) | $ (277,402) | $ (450,125) | $ (517,743) |
Net loss per common share - basic (in dollars per share) | $ (2.21) | $ (2.29) | $ (3.62) | $ (4.29) |
Net loss per common share - diluted (in dollars per share) | $ (2.21) | $ (2.29) | $ (3.62) | $ (4.29) |
Weighted-average common shares used to compute basic net loss per common share (in shares) | 124,659 | 120,896 | 124,387 | 120,646 |
Weighted-average common shares used to compute diluted net loss per common share (in shares) | 124,659 | 120,896 | 124,387 | 120,646 |
Statements of Comprehensive Loss | ||||
Net loss | $ (276,024) | $ (277,402) | $ (450,125) | $ (517,743) |
Other comprehensive income (loss): | ||||
Unrealized (loss) gain on marketable securities | (2,025) | (1,734) | 2,100 | (8,951) |
Foreign currency translation gain (loss) | 4,073 | (2,459) | 5,483 | (83) |
Defined benefit pension plans, net of tax | (4) | 34 | (9) | 69 |
Total other comprehensive income (loss) | 2,044 | (4,159) | 7,574 | (8,965) |
Comprehensive loss | (273,980) | (281,561) | (442,551) | (526,708) |
Net product revenues | ||||
Revenues: | ||||
Total revenues | 305,705 | 213,515 | 582,033 | 400,387 |
Net revenues from collaborations | ||||
Revenues: | ||||
Total revenues | 5,844 | 9,025 | 42,306 | 34,970 |
Royalty revenue | ||||
Revenues: | ||||
Total revenues | $ 7,205 | $ 2,278 | $ 13,705 | $ 2,720 |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 657,800 | $ 866,394 |
Marketable debt securities | 1,372,451 | 1,297,890 |
Marketable equity securities | 27,256 | 28,122 |
Accounts receivable, net | 220,635 | 237,963 |
Inventory | 100,453 | 128,962 |
Prepaid expenses and other current assets | 145,452 | 132,916 |
Total current assets | 2,524,047 | 2,692,247 |
Property, plant and equipment, net | 527,474 | 523,494 |
Operating lease right-of-use assets | 208,801 | 215,136 |
Restricted investments | 49,388 | 49,390 |
Other assets | 92,686 | 66,092 |
Total assets | 3,402,396 | 3,546,359 |
Current liabilities: | ||
Accounts payable | 59,746 | 98,094 |
Accrued expenses | 598,530 | 545,460 |
Operating lease liability | 42,074 | 41,967 |
Deferred revenue | 54,639 | 42,105 |
Liability related to the sale of future royalties | 33,650 | 40,289 |
Total current liabilities | 788,639 | 767,915 |
Operating lease liability, net of current portion | 253,416 | 261,339 |
Deferred revenue, net of current portion | 194,129 | 193,791 |
Convertible debt | 1,018,843 | 1,016,942 |
Liability related to the sale of future royalties, net of current portion | 1,298,446 | 1,252,015 |
Other liabilities | 257,054 | 212,580 |
Total liabilities | 3,810,527 | 3,704,582 |
Commitments and contingencies (Note 13) | ||
Stockholders’ deficit: | ||
Preferred stock, $0.01 par value per share, 5,000 shares authorized and no shares issued and outstanding as of June 30, 2023 and December 31, 2022 | 0 | 0 |
Common stock, $0.01 par value per share, 250,000 shares authorized; 124,901 shares issued and outstanding as of June 30, 2023; 123,925 shares issued and outstanding as of December 31, 2022 | 1,250 | 1,240 |
Additional paid-in capital | 6,647,173 | 6,454,540 |
Accumulated other comprehensive loss | (37,080) | (44,654) |
Accumulated deficit | (7,019,474) | (6,569,349) |
Total stockholders’ deficit | (408,131) | (158,223) |
Total liabilities and stockholders’ deficit | $ 3,402,396 | $ 3,546,359 |